DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171815

Boston keratoprosthesis type 1 - indication, complication and visual outcomes

Kritika Raina, Alka Gupta

Abstract


Background: Diseases affecting the cornea are a major cause of blindness all over the world, second only to cataract in overall importance. In India, there are approximately 6.8 million people who have corneal blindness with vision less than 6/60 in at least one eye, and of these, about 1 million have bilateral corneal blindness.

Methods: The study was conducted in upgraded department of ophthalmology, L.L.R.M. Medical College, Meerut, India from January 2014 to June 2015. It was prospective interventional study. Included those patients who have Failed corneal graft with poor prognosis for further grafting, multiple corneal graft failure, having nearly total corneal neovascularization, vision less than 6/60 with associated other complications in better eye and no vision in opposite eye and Healed Chemical burn and those patients who has end stage glaucoma or RD (retinal detachment), defective perceptions and projection of light and not willing for the procedure.

Results: A total of 20 patients were enrolled for the study which were followed up and assessed over 12 months. It was observed that maximum number of patients were in the age group of 41-60 years (45%) and in the >60 years group are minimum (20%). Among these 14 cases (70%) were male and 6 cases (30%) were female.

Conclusions: The Boston type 1 keratoprosthesis provides visual recovery for eyes with multiple PK failures or with poor prognosis for primary PK, showing excellent retention rates. Most of the cases had a significant improvement in vision after Boston type I KPro implantation.


Keywords


Boston keratoprosthesis, Blindness, Cornea

Full Text:

PDF

References


Prevention of blindness: report of a WHO Study Group. Geneva, World Health Organization. 1973: 10-11 (WHO Technical Report Series, No. 518). Available at http://apps.who.int/ iris/ bitstream/ 10665/ 38222/ 1/ WHO_TRS_518_eng.pdf

Sinha S. Corneal Grafting Surgery- Historical Aspects Vajpayee R.B. Corneal Transplantation. Cornea. 2001;1:2-4.

Kanpolat A, Ciftci OU. The use of rigid gas permeable contact lenses in scarred corneas. CLAO J 1995;21:64-66.

Eye Bank Association of America. Cornea donation andtransplantation statistics Available at http://www.restoresight.org/donation/statistics.htm.Accessed, 2009.

Barber JC. Keratoprosthesis: past and present. Int Ophthalmol Clin. 1988;28:103-109.

Hicks CR, Fotton JH, Chirila TV, Crawford GJ, Constable IJ. Keratoprosthesis: advancing toward a true artificial cornea. SurvOphthalmol. 1997;42:175-89.

Pellier de Quengsy G. PrZcis au coursd’operationsur la chirurgie des yeux. Paris: Didot; 1789.

Chirila TV, Hicks CR. The origins of the artificial cornea: Pellier de Quengsy and his contribution to the modern concept of keratoprosthesis. Gesnerus. 1999;56(1-2):96-106.

Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int ophthalmol clinics. 2007;47(2):61-71.

Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26(5):564-8.

Dohlman CH, Harissi-Dagher M, Graney J. The Boston keratoprosthesis: a new threadless design. Digit J Ophthalmol. 2007;13(3).

Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Kerato prosthesis Study. Ophthalmology. 2006;113(10):1779-84.

Harissi-Dagher M, Beyer J, Dohlman CH, The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin, 2008;48(2):43-51.

Dohlman CH, Harissi-Dagher M, Khan BF, Sippel K, Aquavella JV, Graney JM. Introduction to the use of the Boston keratoprosthesis. Expert Review of Ophthalmology. 2006;1(1):41-8.

Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, Jin YP, Cohen EJ. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989-6.

Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28(3):321-7.

Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640-51.